Showing results (51-60 of 141) with videos related to
Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|February 12, 2020
Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation TherapyZeina Ayoub, Matthew S Ning, Eric D Brooks, et al.Journal of Experimental & Clinical Cancer Research : CR|January 29, 2025
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospectsZahid Rafiq, Mingyo Kang, Hampartsoum B Barsoumian, et al.International Journal of Radiation Oncology, Biology, Physics|May 14, 2015
Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung CancerRitsuko Komaki, Pamela K Allen, Xiong Wei, et al.International Journal of Cancer|June 26, 2021
Financial relationships between industry and principal investigators of US cooperative group randomized cancer clinical trialsApril L Metzger, Adams Kusi Appiah, Christopher M Wright, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled TrialsJennifer K Logan, Chad Tang, Zhongxing Liao, et al.Clinical Lung Cancer|May 13, 2019
Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung CancerHongqi Li, Vivek Verma, Eric D Brooks, et al.Frontiers in Immunology|May 14, 2023
The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapyShonik Ganjoo, Priti Gupta, Halil Ibrahim Corbali, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2014
Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancerTing Xu, Zhongxing Liao, Michael S O'Reilly, et al.Clinical Lung Cancer|April 25, 2018
Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation TherapyCharissa R Kim, Bumyang Kim, Matthew S Ning, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 15, 2023
Five-year overall survival with ipilimumab and stereotactic ablative radiotherapy for metastatic diseaseKewen He, David S Hong, Chad Tang, et al.Pageof 15